Article citationsMore>>
Ngô, C., Sharifzadehgan, S., Lecurieux-Lafayette, C., Belhouari, H., Rousseau, D., Bonsang-Kitzis, H., Crouillebois, L., Balaya, V., Oudard, S., Lécuru, F. and Elaidi, R.T. (2020) Indocyanine Green for Sentinel Lymph Node Detection in Early Breast Cancer: Prospective Evaluation of Detection Rate and Toxicity—The FLUOBREAST Trial. The Breast Journal, 26, 2357-2363.
https://doi.org/10.1111/tbj.14100
has been cited by the following article:
-
TITLE:
Recent Advances in the Tracer Technology Used for Sentinel Lymph Node Biopsy in Breast Cancer
AUTHORS:
Jiali Li, Hongxu Zhang, Dawei Hu
KEYWORDS:
Breast Cancer, Sentinel Lymph Node Biopsy, Tracer
JOURNAL NAME:
Advances in Breast Cancer Research,
Vol.11 No.2,
March
29,
2022
ABSTRACT: The high
incidence of breast cancer poses one of the greatest risks to female health
worldwide. Sentinel lymph node biopsy (SLNB) is the standard of treatment for
patients with axillary lymph node-negative early-stage breast cancer. Herein,
the precise use of tracers is the key to ensuring the success of SLNB. However,
owing to select-few limitations of traditional tracers, their clinical application is limited. New tracer
techniques, such as the near-infrared fluorescent dye method (using
indocyanine green), contrast-enhanced ultrasound, and superparamagnetic iron
oxide nanoparticles are being applied in clinical practice. In this paper, we
review the recent progress in SLNB tracer technology.
Related Articles:
-
Junko Honda, Hisashi Matsuoka, Chieko Hirose, Taeko Nagao, Takahiro Yoshida, Masako Takahashi, Issei Imoto, Mitsunori Sasa
-
Marco Gipponi, Piero Fregatti, Federica Murelli, Paolo Meszaros, Francesca Depaoli, Cecilia Margarino, Paola Baccini, Marina Gualco, Daniele Friedman
-
Camilleri Gail, Borg Grima Karen, Zarb Francis
-
Jiali Li, Hongxu Zhang, Dawei Hu
-
Shinichiro Kashiwagi, Naoyoshi Onoda, Tsutomu Takashima, Yuka Asano, Naoki Aomatsu, Masanori Nakamura, Hidemi Kawajiri, Tetsuro Ishikawa, Kosei Hirakawa